Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-CarboxamidesPer Björk, Tomas Leanderson, David Liberg et al.|PLoS Biology|2009Cited by 358
S100A9 Interaction with TLR4 Promotes Tumor GrowthEva Källberg, Tomas Leanderson, Fredrik Ivars et al.|PLoS ONE|2012Cited by 138
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironmentAnders Olsson, Tomas Leanderson, Luce Bruetschy et al.|Journal for ImmunoTherapy of Cancer|2015Cited by 79